Literature DB >> 23406783

A model of hypoxia-reoxygenation on isolated adult mouse cardiomyocytes: characterization, comparison with ischemia-reperfusion, and application to the cardioprotective effect of regular treadmill exercise.

Lolita Portal1, Valérie Martin, Rana Assaly, Alexandra d'Anglemont de Tassigny, Stéphanie Michineau, Alain Berdeaux, Bijan Ghaleh, Sandrine Pons.   

Abstract

The use of in vitro experimental models of hypoxia-reoxygenation (H/R) that mimic in vivo ischemia-reperfusion represents a powerful tool to investigate cardioprotective strategies against myocardial infarction. Most in vitro studies are performed using neonatal cardiac cells or immortalized embryonic cardiac cell lines which may limit the extrapolation of the results. We developed an H/R model using adult cardiomyocytes freshly isolated from mice and compared its characteristics to the in vivo ischemia-reperfusion conditions. First, cell death was assessed at different values of pH medium during hypoxia (6.2 vs 7.4) to simulate extracellular pH during in vivo ischemia. Cardiomyocyte mortality was aggravated with hypoxia under acidic pH. We next evaluated the relationship between the duration of hypoxia and cell death. Hypoxia time-dependently reduced myocyte viability (-24%, -36%, -53%, and -74% with 1, 1.5, 2, and 3 hours of hypoxia followed by 17 hours of reoxygenation, respectively). We then focused on the duration of reoxygenation as cardioprotective strategies have been reported to have different effects with short and long durations of reperfusion. We observed that cardiomyocyte mortality was increased when the duration of reoxygenation was increased from 2 h to 17 hours. Finally, we used our characterized model to investigate the cardioprotective effect of regular treadmill exercise. Myocyte viability was significantly greater in exercised when compared to sedentary mice (44% and 26%, respectively). Similarly, mice submitted to in vivo ischemia-reperfusion elicited infarct sizes reaching 27%, 43%, and 55% with 20, 30, and 45 minutes of coronary artery occlusion. In addition, infarct size was significantly reduced by exercise. In conclusion, this H/R model of cardiomyocytes freshly isolated from adult mice shows similar characteristics to the in vivo ischemia-reperfusion conditions. The comparison of in vivo and in vitro settings represents a powerful approach to investigate cardioprotective strategies and to distinguish between direct and indirect cardiomyocyte-dependent mechanisms.

Entities:  

Keywords:  cardiomyocytes; exercise; hypoxia; infarction; reoxygenation

Mesh:

Year:  2013        PMID: 23406783     DOI: 10.1177/1074248412475158

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  12 in total

1.  In vitro Models of Ischemia-Reperfusion Injury.

Authors:  Timothy Chen; Gordana Vunjak-Novakovic
Journal:  Regen Eng Transl Med       Date:  2018-05-10

2.  Cardiac function in muscular dystrophy associates with abdominal muscle pathology.

Authors:  Brandon B Gardner; Kayleigh A Swaggart; Gene Kim; Sydeaka Watson; Elizabeth M McNally
Journal:  J Neuromuscul Dis       Date:  2015

3.  Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress.

Authors:  Ying Liu; Donna M Conlon; Xin Bi; Katherine J Slovik; Jianting Shi; Hailey I Edelstein; John S Millar; Ali Javaheri; Marina Cuchel; Evanthia E Pashos; Jahangir Iqbal; M Mahmood Hussain; Robert A Hegele; Wenli Yang; Stephen A Duncan; Daniel J Rader; Edward E Morrisey
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

4.  Potential protective effect of hesperidin on hypoxia/reoxygenation-induced hepatocyte injury.

Authors:  Shilai Li; Jijin Zhu; Ling Pan; Peiqi Wan; Quanlin Qin; Daqing Luo; Wenhui Pan; Yuqing Wei; Yansong Xu; Liming Shang; Xinping Ye
Journal:  Exp Ther Med       Date:  2021-05-13       Impact factor: 2.447

Review 5.  Cardioprotective Potential of Exogenous Ubiquitin.

Authors:  Suman Dalal; Paige L Shook; Mahipal Singh; Krishna Singh
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-10       Impact factor: 3.947

6.  Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms.

Authors:  Colleen Marie Bartman; Yoshimasa Oyama; Kelley Brodsky; Ludmila Khailova; Lori Walker; Michael Koeppen; Tobias Eckle
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Guidelines for experimental models of myocardial ischemia and infarction.

Authors:  Merry L Lindsey; Roberto Bolli; John M Canty; Xiao-Jun Du; Nikolaos G Frangogiannis; Stefan Frantz; Robert G Gourdie; Jeffrey W Holmes; Steven P Jones; Robert A Kloner; David J Lefer; Ronglih Liao; Elizabeth Murphy; Peipei Ping; Karin Przyklenk; Fabio A Recchia; Lisa Schwartz Longacre; Crystal M Ripplinger; Jennifer E Van Eyk; Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-12       Impact factor: 4.733

8.  Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Alejandro Hidalgo; Nick Glass; Dmitry Ovchinnikov; Seung-Kwon Yang; Xinli Zhang; Stuart Mazzone; Chen Chen; Ernst Wolvetang; Justin Cooper-White
Journal:  APL Bioeng       Date:  2018-03-20

9.  A human in vitro platform for the evaluation of pharmacology strategies in cardiac ischemia.

Authors:  Carlota Oleaga; Golareh Jalilvand; Gregg Legters; Candace Martin; Gail Ekman; Christopher W McAleer; Christopher J Long; James J Hickman
Journal:  APL Bioeng       Date:  2019-08-13

10.  A small molecule inhibitor of Nox2 and Nox4 improves contractile function after ischemia-reperfusion in the mouse heart.

Authors:  Ferenc L M Szekeres; Erik Walum; Per Wikström; Anders Arner
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.